Safety perspectives on presently considered drugs for the treatment of COVID‐19

Intense efforts are underway to evaluate potential therapeutic agents for the treatment of COVID‐19. In order to respond quickly to the crisis, the repurposing of existing drugs is the primary pharmacological strategy. Despite the urgent clinical need for these therapies, it is imperative to conside...

Descripción completa

Detalles Bibliográficos
Autores principales: Penman, Sophie L., Kiy, Robyn T., Jensen, Rebecca L., Beoku‐Betts, Christopher, Alfirevic, Ana, Back, David, Khoo, Saye H., Owen, Andrew, Pirmohamed, Munir, Park, B. Kevin, Meng, Xiaoli, Goldring, Christopher E., Chadwick, Amy E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404855/
https://www.ncbi.nlm.nih.gov/pubmed/32681537
http://dx.doi.org/10.1111/bph.15204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404855/
https://www.ncbi.nlm.nih.gov/pubmed/32681537
http://dx.doi.org/10.1111/bph.15204

Ejemplares similares